Loading…
Disclosed for 71 months, Nov 2020 to Sep 2026.
quant ESG Integration Strategy Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In March 2021 it disclosed 29 stocks worth ₹15.5 Cr, up ₹2.3 Cr from Feb 2021. Its largest positions were Fortis Healthcare Limited (9.5%), Infosys Limited (7.3%), General Insurance Corporation of India (6.9%); the ten largest together made up 61.6% of the portfolio, and IT - Software was the biggest sector at 19.2% of its equity. Cash and debt stood at <0.1%. Compared with Feb 2021 the fund entered 8 new stocks and exited 4.
Top-10 weight is higher than 85% of peers
Holds more stocks than 13% of peers
Holds more cash than 1% of peers
What these mean: concentration · cash
Every line the fund disclosed, with the change against Feb 2021. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Fortis Healthcare Limited | 9.51% | up 0.61 pts | ₹1.5 Cr | up ₹30 L | Added |
| Infosys Limited | 7.34% | down 0.57 pts | ₹1.1 Cr | up ₹10 L | Added |
| General Insurance Corporation of India | 6.90% | down 0.80 pts | ₹1.1 Cr | up ₹6 L | Added |
| Oracle Financial Services Software Limited | 6.00% | down 0.72 pts | ₹93 L | up ₹5 L | Added |
| India Limited | 5.76% | down 0.66 pts | ₹89 L | up ₹5 L | Added |
| Rossari Biotech Limited | 5.66% | down 0.70 pts | ₹88 L | up ₹4 L | Added |
| Sun Pharmaceutical Industries Limited | 5.64% | up 5.64 pts | ₹87 L | up ₹87 L | New |
| Bharti Airtel Limited | 5.62% | down 3.35 pts | ₹87 L | down ₹31 L | Trimmed |
| Alembic Pharmaceuticals Limited | 4.63% | down 0.57 pts | ₹72 L | up ₹3 L | Added |
| Aavas Financiers Limited | 4.54% | down 0.44 pts | ₹70 L | up ₹5 L | Added |
| Zee Entertainment Enterprises Limited | 3.94% | up 3.94 pts | ₹61 L | up ₹61 L | New |
| Bharat Petroleum Corporation Limited | 3.69% | up 0.50 pts | ₹57 L | up ₹15 L | Added |
| Stylam Industries Limited | 2.81% | up 0.96 pts | ₹43 L | up ₹19 L | Added |
| Shriram City Union Finance Limited | 2.64% | down 0.93 pts | ₹41 L | down ₹6 L | Trimmed |
| Tata Consultancy Services Limited | 2.61% | down 0.19 pts | ₹40 L | up ₹4 L | Added |
| Fermenta Biotech Limited | 2.37% | down 0.72 pts | ₹37 L | down ₹4 L | Trimmed |
| Tech Mahindra Limited | 2.36% | down 0.21 pts | ₹37 L | up ₹3 L | Added |
| Zydus Lifesciences Limited | 2.28% | down 0.37 pts | ₹35 L | up ₹0 L | Added |
| JB Chemicals & Pharmaceuticals Limited | 2.23% | up 2.23 pts | ₹35 L | up ₹35 L | New |
| ICICI Lombard General Insurance Company Limited | 2.16% | down 0.34 pts | ₹33 L | up ₹1 L | Added |
| Hindustan Petroleum Corporation Limited | 2.12% | down 0.46 pts | ₹33 L | down ₹1 L | Trimmed |
| Thyrocare Technologies Limited | 2.04% | up 2.04 pts | ₹32 L | up ₹32 L | New |
| Nureca Limited | 1.55% | down 0.51 pts | ₹24 L | down ₹3 L | Trimmed |
| Jubilant Pharmova Limited | 1.47% | down 0.49 pts | ₹23 L | down ₹3 L | Trimmed |
| Canara Bank | 1.23% | down 0.26 pts | ₹19 L | down ₹1 L | Trimmed |
| L&T Technology Services Limited | 0.94% | up 0.94 pts | ₹15 L | up ₹15 L | New |
| Tata Elxsi Limited | 0.87% | up 0.87 pts | ₹13 L | up ₹13 L | New |
| Jubilant Ingrevia Limited | 0.56% | up 0.56 pts | ₹9 L | up ₹9 L | New |
| Aurobindo Pharma Limited | 0.51% | up 0.51 pts | ₹8 L | up ₹8 L | New |
| Cash, TREPS & receivables | 0.01% | down 0.08 pts | ₹0 L | down ₹1 L | Trimmed |
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Compared with
Since Feb 2021, the weight rose most in Pharmaceuticals & Biotechnology (+6.2 pts) and Entertainment (+3.9 pts), and fell most in Telecom - Services (−3.4 pts) and IT - Software (−2.1 pts).
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
| Sector | Dec 2020 | Feb 2021 | Mar 2021 |
|---|---|---|---|
| IT - Software | 29.0% | 21.3% | 19.2% |
| Pharmaceuticals & Biotechnology | 32.0% | 12.9% | 19.1% |
| Healthcare Services | 8.9% | 8.9% | 11.6% |
| Insurance | 2.8% | 10.2% | 9.1% |
| Finance | — | 8.6% | 7.2% |
| Chemicals & Petrochemicals | — | 6.4% | 6.2% |
| Petroleum Products | — | 5.8% | 5.8% |
| Power | 3.9% | 6.4% | 5.8% |
| Telecom - Services | 6.2% | 9.0% | 5.6% |
| Entertainment | — | — | 3.9% |
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| 2 |
| −2.0% |
| 4.7% |
| 7% |
| May 2026 | ₹294 Cr | 12 | 2 | 4 | −4.9% | 1.2% | 6% |
| Apr 2026 | ₹264 Cr | 14 | 3 | 5 | 0.6% | 6.7% | 6% |
| Mar 2026 | ₹226 Cr | 16 | 3 | 2 | −5.9% | 1.2% | 6% |
| Feb 2026 | ₹257 Cr | 15 | 5 | 2 | 0.8% | 6.6% | 6% |
| Jan 2026 | ₹252 Cr | 12 | 4 | 6 | −4.0% | 0.3% | 5% |
| Dec 2025 | ₹269 Cr | 14 | 4 | 7 | −5.1% | 0.4% | 5% |
| Nov 2025 | ₹273 Cr | 17 | 5 | 5 | 4.6% | 9.8% | 439% |
| Oct 2025 | ₹274 Cr | 17 | 5 | 5 | 5.3% | 9.7% | 386% |
| Sep 2025 | ₹277 Cr | 17 | 1 | 2 | −0.7% | 2.2% | 324% |
| Aug 2025 | ₹273 Cr | 18 | 3 | 2 | −4.6% | 0.2% | 327% |
| Jul 2025 | ₹285 Cr | 17 | 4 | 2 | −4.1% | 1.4% | 342% |
| Jun 2025 | ₹305 Cr | 15 | 2 | 0 | −4.1% | 0.4% | 357% |
| May 2025 | ₹299 Cr | 13 | 4 | 6 | −2.8% | 0.8% | 385% |
| Apr 2025 | ₹284 Cr | 15 | 2 | 6 | −1.9% | 0.8% | 392% |
| Mar 2025 | ₹277 Cr | 19 | 1 | 2 | −1.6% | 0.5% | 432% |
| Feb 2025 | ₹260 Cr | 20 | 8 | 4 | 0.7% | 0.7% | 439% |
| Jan 2025 | ₹288 Cr | 16 | 3 | 3 | 0.5% | 0.5% | 451% |
| Dec 2024 | ₹298 Cr | 16 | 1 | 5 | 3.3% | 3.3% | 470% |
| Nov 2024 | ₹312 Cr | 20 | 3 | 1 | 0.9% | 0.9% | 5% |
| Oct 2024 | ₹309 Cr | 18 | 4 | 1 | 1.6% | 1.6% | 5% |
For any of the 47 earlier months, choose it in “Portfolio as of” at the top of the page.